POLLS     NHL STATS     SEARCH

TRENDING NOW


PUCKREPORTER  |  NHL  |  INJURIES

BREAKING: Winnipeg Jets Forward Gabriel Vilardi Diagnosed With Enlarged Spleen


PUBLICATION
Samer Dagher
March 15, 2024  (3:51 PM)
SHARE THIS STORY
FOLLOW US



The Winnipeg Jets have been missing key forward Gabriel Vilardi for several games, and head coach Rick Bowness delivered disappointing news to fans and analysts on Friday.

Winnipeg Jets Gabriel Vilardi Diagnosed With Enlarged Spleen

Bowness revealed that Vilardi is dealing with an enlarged spleen, requiring treatment before he can return to the lineup. Consequently, he is expected to sit out the entire upcoming five-game road trip through the Eastern Conference, with no clear timeline for his return.
#NHLJets coach Rick Bowness says Gabe Vilardi has been diagnosed with an enlarged spleen. This is something that recently was discovered. He won't travel with the team for the five-game trip. No timeline on a return. He's getting treatment.

The discovery of Vilardi's enlarged spleen came during his recovery process from an undisclosed upper-body injury sustained on February 29 against the Dallas Stars. According to team insider John Lu, this condition is separate from the injury that initially sidelined him at the beginning of March. Initially considered day-to-day, Vilardi's status shifted to week-to-week and now remains indefinite as the focus shifts to treating his spleen condition.
Vilardi's absence is a significant setback for the Jets, who currently hold third place in the Central Division with 87 points. With tonight's game against the Anaheim Ducks crucial in the tight race for postseason contention in the Western Conference, the Jets will have to make do without Vilardi's contributions on the ice.
We wish him a speedy recovery!
POLL
15 MARS   |   75 ANSWERS
BREAKING: Winnipeg Jets Forward Gabriel Vilardi Diagnosed With Enlarged Spleen

Do you think the Jets will make it through the first round?

Yes4965.3 %
No2634.7 %
LIST OF POLLS
Latest 10 stories

PUCKREPORTER.COM
COPYRIGHT @2024 - ALL RIGHTS RESERVED.
TERMS  -  POLICIES  -  CONSENT